Neurology® Podcast

American Academy of Neurology
undefined
Sep 6, 2021 • 24min

Neuroprosthesis for Anarthria; Clinical Progression of LBD

In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.
undefined
Sep 1, 2021 • 53min

Management of Myasthenia Gravis (September 2021 Neurology Recall)

The September 2021 replay of past episodes showcases a selection of interviews focused on the management of myasthenia gravis. The selected interviews feature Dr. Ted Burns and Dr. Stacey Clardy in conversation with Drs. Gil Wolfe, Joseph Shrager, and Pushpa Narayanaswami before closing with before closing with notes from Dr. Ted Burns on MuSK myasthenia gravis.
undefined
Aug 30, 2021 • 16min

Using RT-QuIC to Diagnose DLB; Central Hypersomnia in Multiple Sclerosis

In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.
undefined
Aug 23, 2021 • 30min

Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series

In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients' out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.
undefined
Aug 16, 2021 • 23min

Patient Perceptions of FDA Approval; Part 3 of the Thunderclap Headache Series

In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.
undefined
Aug 9, 2021 • 23min

Coma Induction in Status Epilepticus; Part 2 of the Thunderclap Headache Series

In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week's Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
undefined
Aug 2, 2021 • 23min

Psychogenic Nonepileptic Seizures in Children and Adolescents; Part 1 of the Thunderclap Headache Series

In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week's Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
undefined
Aug 1, 2021 • 1h 29min

Perspectives on Aducanumab Approval (Neurology Recall August 2021)

This month's replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.
undefined
Jul 26, 2021 • 17min

Impact of Thymectomy on Myasthenia Gravis Remission

Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.
undefined
Jul 19, 2021 • 26min

Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation

In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app